Read Belgiums UCB is making a bold move in neuroscience.The company has announced plans to acquire Neurona Therapeutics in a deal worth up to $1.15 billion signaling growing confidence in next-generation cell therapies for neurological diseases
The 2026 regulatory developments The status of several peptides shifted recently
Plus, we see a break from precedent in how the FDA selects priority review vouchers, and more
Best for Maximum Weight Loss Injectable GLP-1s outperform oral GLP-1s in terms of weight loss in clinical trials, but results are mixed in real-world settings
ucfguy01 September 18, 2020, 2:32pm 39 Im taking .1 ml every morning 5 days a week
9 Additionally, it has been shown to reduce the risk of developing T2D by 60%, regardless of whether patients have prediabetes or normal blood sugar levels